rdf:type |
|
lifeskim:mentions |
umls-concept:C0004599,
umls-concept:C0007120,
umls-concept:C0008551,
umls-concept:C0019425,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0241888,
umls-concept:C0443252,
umls-concept:C0684262,
umls-concept:C0887889,
umls-concept:C1550176
|
pubmed:issue |
4
|
pubmed:dateCreated |
1983-2-14
|
pubmed:abstractText |
Two familial hypercholesterolemic heterozygote patients were treated for a period of 2 years using an extracorporeal technique involving batch affinity chromatography. In both cases LDL-cholesterol levels were drastically lowered and HDL-cholesterol levels were normalized. No untoward side effects were noted during the 2 year experimental period. These results confirm the safety and simplicity of this technique to lower considerably LDL-cholesterol levels in whole blood of familial hypercholesterolemic patients who do not adequately respond to conventional medical treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0098-6127
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
286-300
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7181673-Adult,
pubmed-meshheading:7181673-Angina Pectoris,
pubmed-meshheading:7181673-Cholesterol,
pubmed-meshheading:7181673-Cholesterol, HDL,
pubmed-meshheading:7181673-Cholesterol, LDL,
pubmed-meshheading:7181673-Chromatography, Affinity,
pubmed-meshheading:7181673-Female,
pubmed-meshheading:7181673-Heterozygote,
pubmed-meshheading:7181673-Humans,
pubmed-meshheading:7181673-Hyperlipoproteinemia Type II,
pubmed-meshheading:7181673-Lipoproteins, HDL,
pubmed-meshheading:7181673-Lipoproteins, LDL,
pubmed-meshheading:7181673-Male
|
pubmed:year |
1982
|
pubmed:articleTitle |
Long term treatment of two familial hypercholesterolemic heterozygote patients with batch affinity chromatography (BAC).
|
pubmed:publicationType |
Journal Article
|